Ignite Creation Date:
2024-05-06 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 12:51 PM
Study NCT ID:
NCT03631472
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-05-09
First Post:
2018-08-13
Brief Title:
Gala Early Feasibility Study of RheOx
Sponsor:
Gala Therapeutics Inc
Organization:
Gala Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-06
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-13
First Submit QC Date:
August 14 2018
Study First Post Date:
2018-08-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-11
Last Update Post Date:
2022-05-09
Last Update Post Date Type:
ACTUAL